Stock listing
Alphamab Oncology
Selected listing: 3NK · DUS · EUR · DE
Alphamab Oncology (Dusseldorf:3NK), Health Technology. Latest release Sep 28, 2026: Next Day Disclosure Return.
- Ticker
- Dusseldorf:3NK
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Dusseldorf
- Currency
- EUR
Latest news from Alphamab Oncology
Next Day Disclosure Return
September 28, 2026
2026 ASCO Preview | Alphamab Oncology to Present Clinical Data of TROP2/HER3 Bispecific ADC JSKN016 for HER2-Negative Breast Cancer
April 22, 2026
2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation
April 22, 2026
Alphamab Oncology Announces the Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 as Neoadjuvant Treatment for Breast Cancer Has Met the Primary Endpoint
April 1, 2026
Alphamab Oncology Reports Full Year 2025 Financial Results and Business Highlights
March 26, 2026
Research Alphamab Oncology
Alternate listings
9966:HKEX
HK · HKD
Alternate listing for Alphamab Oncology; the primary context on this page is 3NK:DUS.
A2PWDV:LSX
DE · EUR
Alternate listing for Alphamab Oncology; the primary context on this page is 3NK:DUS.
A2PWDV:LS
DE · EUR
Alternate listing for Alphamab Oncology; the primary context on this page is 3NK:DUS.
3NK:GETTEX
DE · EUR
Alternate listing for Alphamab Oncology; the primary context on this page is 3NK:DUS.
3NK:FWB
DE · EUR
Alternate listing for Alphamab Oncology; the primary context on this page is 3NK:DUS.
3NK:MUN
DE · EUR
Alternate listing for Alphamab Oncology; the primary context on this page is 3NK:DUS.
ALMOF:OTC
US · USD
Alternate listing for Alphamab Oncology; the primary context on this page is 3NK:DUS.
3NK:SWB
DE · EUR
Alternate listing for Alphamab Oncology; the primary context on this page is 3NK:DUS.
3NK:TRADEGATE
DE · EUR
Alternate listing for Alphamab Oncology; the primary context on this page is 3NK:DUS.